{"cdcTestId":"2019-0001","testcaseName":"Zoster: Dose #2 (Shingrix) administered at 4 weeks - 5 days after dose #1","vaccineGroup":"ZOSTER","evaluationTestType":"Interval: Below Absolute Minimum","forecastTestType":"Recommended based on minimum interval from invalid dose","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1972-09-21T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-14T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-11T00:00:00","recommendedDate":"2022-12-09T00:00:00","pastDueDate":"2023-06-10T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-14T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2018-03-27T20:00:00","dateUpdated":"2022-09-27T08:48:39.996","generalDescription":"This test case describes that when a patient is administered the second dose of Shingrix vaccine at less than 4 weeks - 4 days, that the dose is considered not valid.","changedInVersion":"4.27","reasonForChange":"v 4.27 Updated Forecast minimum interval from 8 weeks to 4 weeks, to align with ACIP recommendations."}